Optometrist · Bronx, NY
NPI
1629302658
Since 2009
Specialty
Optometrist
Code 152W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
731 Lydig Ave
Bronx, NY, 10462
Phone (718) 829-2160
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
811 services
Medicare patients, 2024
153
Average age 71
Drug cost, 2024
$1.8M
3,885 prescriptions
Company payments, 2025
$1,177
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Diana Ilyasova was code 68761 (eye), 332 times for 61 patients. In total Diana Ilyasova billed 811 services in 21 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 68761 Eye | Office | 332 | 61 | $83.17 | $28K |
| 92012 Ophthalmological E&M | Office | 128 | 74 | $75.36 | $9,646 |
| 92014 Ophthalmological E&M | Office | 76 | 74 | $106.12 | $8,065 |
| 92133 Computerized Ophthalmic Imaging | Office | 68 | 64 | $30.42 | $2,069 |
| 92083 Vision, Hearing, and Speech Services | Office | 62 | 49 | $55.16 | $3,420 |
| 92004 Ophthalmological E&M | Office | 34 | 34 | $122.06 | $4,150 |
| 92250 Angiography | Office | 31 | 30 | $28.70 | $890 |
| 92285 Standard X-ray | Office | 14 | 13 | $18.64 | $261 |
| 92134 Computerized Ophthalmic Imaging | Office | 12 | 11 | $32.50 | $390 |
| 92286 Standard X-ray | Office | 11 | 11 | $35.44 | $390 |
By year: 2022 $56K for 697 services; 2023 $54K for 695 services; 2024 $67K for 811 services.
Medicare prescription drug claims, 2024
In 2024, the drug Diana Ilyasova prescribed most often to Medicare patients was Restasis (Cyclosporine), with 874 prescriptions and refills. In total Diana Ilyasova wrote 3,885 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 874 | 969 | 208 | $587K |
| Latanoprost Generic | 716 | 831 | 139 | $4,683 |
| Vyzulta Latanoprostene Bunod | 349 | 448 | 68 | $122K |
| Cequa Cyclosporine | 304 | 336 | 85 | $190K |
| Cyclosporine Generic | 266 | 468 | 82 | $127K |
| Combigan Brimonidine Tartrate/Timolol | 188 | 351 | 52 | $79K |
| Lumigan Bimatoprost | 170 | 365 | 59 | $104K |
| Xiidra Lifitegrast | 90 | 96 | 22 | $65K |
| Azelastine Hcl Generic | 87 | 88 | 22 | $791 |
| Rhopressa Netarsudil Mesylate | 86 | 98 | 18 | $30K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 82 | 167 | 23 | $18K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 57 | 98 | 16 | $862 |
| Timolol Maleate Generic | 56 | 92 | 15 | $1,533 |
| Dorzolamide Hcl Generic | 55 | 74 | 17 | $712 |
| Prednisolone Acetate Generic | 49 | 63 | 29 | $2,409 |
Brand drugs: 2,785 claims; generic drugs: 1,100 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Diana Ilyasova $1,177 ($1,177 in general payments such as food, travel and fees) from 9 companies. The largest payer was Dompe US, Inc. with $227.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.